Common limitations of performance metrics in biomedical image analysis
Jan 1, 2021··
0 min read
Matthias Eisenmann, Minu Dietlinde Tizabi, Carole H Sudre, Tim Rädsch, Michela Antonelli, Tal Arbel, Spyridon Bakas, Jorge Cardoso, Veronika Cheplygina, Keyvan Farahani, Ben Glocker, Doreen Heckmann-Nötzel, Fabian Isensee, Pierre Jannin, Charles Kahn, Jens Kleesiek, Tahsin Kurc, Michal Kozubek, Bennett a Landman, Geert Litjens, Klaus Maier-Hein, Anne Lousise Martel, Henning Müller, Jens Petersen, Mauricio Reyes, Nicola Rieke, Bram Stieltjes, Ronald M Summers, Sotirios a Tsaftaris, Bram Van Ginneken, Annette Kopp-Schneider, Paul Jäger, Lena Maier-Hein Annika Reinke
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma. It is characterized by a heterogeneous morphology, genetic changes and clinical behavior. A small specific subgroup of DLBCL, harbouring a MYC gene translocation is associated with worse patient prognosis and outcome. Typically, the MYC translocation is assessed with a molecular test (FISH), that is expensive and time-consuming. Our hypothesis is that genetic changes, such as translocations could be visible as changes in the morphology of an HE-stained specimen. However, it has not proven possible to use morphological criteria for the detection of a MYC translocation in the diagnostic setting due to lack of specificity. In this paper, we apply a deep learning model to automate detection of the MYC translocations in DLBCL based on HE-stained specimens. The proposed method works at the whole-slide level and was developed based on a multicenter data cohort of 91 patients. All specimens were stained with HE, and the MYC translocation was confirmed using fluorescence in situ hybridization (FISH). The system was evaluated on an additional 66 patients, and obtained AUROC of 0.83 and accuracy of 0.77. The proposed method presents proof of a concept giving insights in the applicability of deep learning methods for detection of a genetic changes in DLBCL. In future work we will evaluate our algorithm for automatic pre-screen of DLBCL specimens to obviate FISH analysis in a large number of patients.
Type
Publication
Medical Imaging with Deep Learning